Learn About Hypophosphatemia
Hypophosphatemia is a low level of phosphorus (phosphate) in the blood.
Low blood phosphate; Phosphate - low; Hyperparathyroidism - low phosphate
The following may cause hypophosphatemia:
- Alcoholism
- Antacids
- Certain medicines, including insulin, acetazolamide, foscarnet, imatinib, intravenous iron, niacin, pentamidine, sorafenib, and tenofovir
- Fanconi syndrome
- Fat malabsorption in the gastrointestinal tract
- Hyperparathyroidism (overactive parathyroid gland)
- Starvation
- Too little vitamin D
Symptoms may include:
- Bone pain
- Confusion
- Muscle weakness
- Seizures
Treatment depends on the cause. Phosphate can be given by mouth or through a vein (IV).
Private Diagnostic Clinic PLLC
Thomas Weber is an Endocrinologist in Durham, North Carolina. Dr. Weber is rated as an Elite provider by MediFind in the treatment of Hypophosphatemia. His top areas of expertise are Hypophosphatemia, Rickets, Malnutrition, X-Linked Hypophosphatemia, and Parathyroidectomy.
Maria Brandi practices in Florence, Italy. Brandi is rated as an Elite expert by MediFind in the treatment of Hypophosphatemia. Their top areas of expertise are Osteoporosis, Hypophosphatemia, Postmenopausal Osteoporosis, Parathyroidectomy, and Hormone Replacement Therapy (HRT).
Leanne Ward practices in Ottawa, Canada. Ms. Ward is rated as an Elite expert by MediFind in the treatment of Hypophosphatemia. Her top areas of expertise are Rickets, X-Linked Hypophosphatemia, Hypophosphatemia, and Malnutrition.
How well you do depends on what has caused the condition.
Contact your provider if you have muscle weakness or confusion.
Summary: The purpose of this clinical trial is to evaluate the efficacy and safety of Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the treatment of participants with mild, moderate, and severe hypophosphatemia. The main questions it aims to answer are: Does enteral supplementation of Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules elevate participants' serum...
Summary: A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
Published Date: December 31, 2023
Published By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Chonchol M, Smogorzewski MJ, Stubbs, JR, Yu ASL. Disorders of calcium, magnesium, and phosphate balance. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 18.
Klemm KM, Klein MJ, Zhang Y. Biochemical markers of bone metabolism. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 16.
Yu ASL. Diseases of magnesium and phosphorus. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 105.